165 related articles for article (PubMed ID: 17426779)
21. Genetic variants in the chemokines and chemokine receptors in Chagas disease.
Flórez O; Martín J; González CI
Hum Immunol; 2012 Aug; 73(8):852-8. PubMed ID: 22537745
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis.
Nadif R; Mintz M; Rivas-Fuentes S; Jedlicka A; Lavergne E; Rodero M; Kauffmann F; Combadière C; Kleeberger SR
Cytokine; 2006 Feb; 33(3):171-8. PubMed ID: 16524739
[TBL] [Abstract][Full Text] [Related]
23. Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes.
Neumeier M; Bauer S; Brühl H; Eisinger K; Kopp A; Abke S; Walter R; Schäffler A; Buechler C
Cytokine; 2011 Dec; 56(3):573-80. PubMed ID: 21890375
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts.
Rüster M; Sperschneider H; Fünfstück R; Stein G; Gröne HJ
Clin Nephrol; 2004 Jan; 61(1):30-9. PubMed ID: 14964455
[TBL] [Abstract][Full Text] [Related]
25. Analysis of gene polymorphisms in the regulatory region of MCP-1, RANTES, and CCR5 in liver transplant recipients.
Schröppel B; Fischereder M; Lin M; Marder B; Schiano T; Krämer BK; Murphy B
J Clin Immunol; 2002 Nov; 22(6):381-5. PubMed ID: 12462338
[TBL] [Abstract][Full Text] [Related]
26. Chemokine and chemokine receptor dynamics during genital chlamydial infection.
Belay T; Eko FO; Ananaba GA; Bowers S; Moore T; Lyn D; Igietseme JU
Infect Immun; 2002 Feb; 70(2):844-50. PubMed ID: 11796619
[TBL] [Abstract][Full Text] [Related]
27. Increased T cell chemotaxis response to Staphylococcus enterotoxin B mediated human endothelial cell damage in vitro.
Xiao Z; Wu L; Mo H; Kong T
Scand J Immunol; 2012 Feb; 75(2):147-56. PubMed ID: 21923737
[TBL] [Abstract][Full Text] [Related]
28. Chemokine MCP1/CCL2 and RANTES/CCL5 gene polymorphisms influence Henoch-Schönlein purpura susceptibility and severity.
Yu HH; Liu PH; Yang YH; Lee JH; Wang LC; Chen WJ; Chiang BL
J Formos Med Assoc; 2015 Apr; 114(4):347-52. PubMed ID: 25839768
[TBL] [Abstract][Full Text] [Related]
29. Allograft renal rejection and chemokine polymorphism.
Gorgi Y; Sfar I; Jendoubi-Ayed S; Makhlouf M; Rhomdhane TB; Bardi R; Aouadi H; Abdallah TB; Abderrahim E; Ayed K
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):18-23. PubMed ID: 21196609
[TBL] [Abstract][Full Text] [Related]
30. CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan.
Konishi I; Horiike N; Hiasa Y; Michitaka K; Onji M
Intervirology; 2004; 47(2):114-20. PubMed ID: 15192276
[TBL] [Abstract][Full Text] [Related]
31. The role of C-C chemokines and their receptors in osteoarthritis.
Yuan GH; Masuko-Hongo K; Sakata M; Tsuruha J; Onuma H; Nakamura H; Aoki H; Kato T; Nishioka K
Arthritis Rheum; 2001 May; 44(5):1056-70. PubMed ID: 11352237
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms in the chemokine and chemokine receptors: impact on clinical course and therapy of the human immunodeficiency virus type 1 infection (HIV-1).
Reiche EM; Bonametti AM; Voltarelli JC; Morimoto HK; Watanabe MA
Curr Med Chem; 2007; 14(12):1325-34. PubMed ID: 17504215
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of IL-17A, IL-17F, IL-23R, VDR, CCL2, CCL5, CCR2, and CCR5 gene polymorphisms and expression in Chinese individuals with syphilis.
Hu WL; Ren H; Xu BF; Zhang JP; Zhang RL; Wang QQ; Zhang TT
J Cell Biochem; 2018 Dec; 119(12):10151-10164. PubMed ID: 30171709
[TBL] [Abstract][Full Text] [Related]
34. Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer.
Kucukgergin C; Isman FK; Cakmakoglu B; Sanli O; Seckin S
DNA Cell Biol; 2012 Aug; 31(8):1418-24. PubMed ID: 22612293
[TBL] [Abstract][Full Text] [Related]
35. The atypical chemokine receptor ACKR2 drives pulmonary fibrosis by tuning influx of CCR2
Russo RC; Savino B; Mirolo M; Buracchi C; Germano G; Anselmo A; Zammataro L; Pasqualini F; Mantovani A; Locati M; Teixeira MM
Am J Physiol Lung Cell Mol Physiol; 2018 Jun; 314(6):L1010-L1025. PubMed ID: 29469612
[TBL] [Abstract][Full Text] [Related]
36. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
[TBL] [Abstract][Full Text] [Related]
37. The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allografts.
Solomon MF; Kuziel WA; Simeonovic CJ
Cell Transplant; 2004; 13(5):503-14. PubMed ID: 15565863
[TBL] [Abstract][Full Text] [Related]
38. Chemokine and chemokine receptor gene polymorphism in Tunisian hemodialysis patients with HCV infection.
Ksiaa Cheikh Rouhou L; Gorgi YL; Skhiri HA; Aouadi H; Ayed SJ; Sfar I; Ayed K; Ben Abdallah T
Arab J Nephrol Transplant; 2011 Sep; 4(3):117-24. PubMed ID: 22026334
[TBL] [Abstract][Full Text] [Related]
39. High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients.
Yeregui E; Viladés C; Domingo P; Ceausu A; Pacheco YM; Veloso S; Inciarte A; Vidal-González J; Peraire M; Perpiñán C; Falcó V; Masip J; Alba V; Vargas M; Martí A; Reverté L; Mallolas J; Vidal F; Peraire J; Rull A
EBioMedicine; 2020 Dec; 62():103077. PubMed ID: 33166788
[TBL] [Abstract][Full Text] [Related]
40. The inflammatory chemokines CCL2 and CCL5 in breast cancer.
Soria G; Ben-Baruch A
Cancer Lett; 2008 Aug; 267(2):271-85. PubMed ID: 18439751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
